Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$218K Sell
7,898
-248
-3% -$5.48K ﹤0.01% 2061
2026
Q1
$119K Buy
8,146
+521
+7% +$7.65K ﹤0.01% 2292
2025
Q4
$96.4K Sell
7,625
-1,426
-16% -$21K ﹤0.01% 2391
2025
Q3
$139K Sell
9,051
-103
-1% -$1.66K ﹤0.01% 2188
2025
Q2
$144K Sell
9,154
-56
-0.6% -$849 ﹤0.01% 2229
2025
Q1
$176K Sell
9,210
-2,833
-24% -$62K ﹤0.01% 2080
2024
Q4
$287K Sell
12,043
-30,480
-72% -$851K ﹤0.01% 1817
2024
Q3
$1.19M Sell
42,523
-1,988
-4% -$56.1K ﹤0.01% 1058
2024
Q2
$1.16M Buy
44,511
+4,513
+11% +$93.9K ﹤0.01% 1040
2024
Q1
$875K Sell
39,998
-5,311
-12% -$114K ﹤0.01% 1181
2023
Q4
$1.05M Buy
45,309
+36,764
+430% +$740K ﹤0.01% 1088
2023
Q3
$169K Sell
8,545
-430
-5% -$8.47K ﹤0.01% 1904
2023
Q2
$203K Sell
8,975
-200
-2% -$4.03K ﹤0.01% 1856
2023
Q1
$180K Sell
9,175
-465
-5% -$8.93K ﹤0.01% 1908
2022
Q4
$166K Buy
+9,640
New +$171K ﹤0.01% 1963

Other funds holding RXO

US Bancorp's RXO Position: Q2 2026 in Review

US Bancorp reduced its RXO (RXO) stake by 3% in Q2 2026, selling an estimated $5.48K and leaving 7,898 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #2061.

US Bancorp first reported a position in RXO in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.19M in Q3 2024. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • US Bancorp held 7,898 shares of RXO worth $218K as of Q2 2026.
  • US Bancorp sold 248 RXO shares in Q2 2026, an estimated $5.48K.
  • RXO made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #2061 holding.
  • US Bancorp first reported a position in RXO in Q4 2022 and has held it in 15 quarters since.
  • US Bancorp's RXO position peaked at $1.19M in Q3 2024.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.